Argenx Se (ARGX) - News Archive

In a month marked by dynamic market fluctuations, health care investors and industry stakeholders are closely monitoring leading biopharmaceutical companies like Argenx SE. As we delve into the latest financial and oper...

In recent news, two analysts have expressed their bullish sentiments towards Arcus Biosciences (RCUS) and Argenx SE (ARGX). This article aims to delve into the various news updates surrounding Argenx SE, an emerging gen...

In recent news, Johnson & Johnson (J&J) has emerged as a formidable competitor to Argenx s Vyvgart with promising results from its Phase III clinical trial for nipocalimab. The data showcases the antibody s effectivenes...

In the field of immunology, Argenx SE has been making significant strides in addressing severe autoimmune diseases. This article highlights recent developments in Argenx s multifocal motor neuropathy data presentation,...

Date: Monday, June 24, 2024The stock market exhibited a predominantly positive trend during today's trading session, after a mixed performance on Friday. While the majority of indices remained in the...

The stock market took a dip on Wednesday, December 20, 2023, in response to a series of dismal earnings reports from major corporations. Companies like Abm Industries Inc, Steelcase Inc, Heico Corpor...

Stock Market Dips as Earnings Reports and Crypto Performance Influence TradingIn a tumultuous morning of trading on Tuesday, September 26, the stock market experienced a downward trend, influenced by...

In a highly dynamic market, the trading week kicked off with a moderate rise on Monday, July 17, 2023. Bolstered by strong performances within the In Vitro & In Vivo Diagnostic Substances industry, s...